Taiwan and the US completed two days of high level economic talks in Washington on Wednesday, but did not reach agreements to end any of the major trade disputes between the two countries, chief Taiwanese negotiator John Deng (
The talks, under the bilateral Trade and Investment Framework Agreement (TIFA), were held at the offices of the US Trade Representative (USTR) and covered a wide range of issues, including agriculture, pharmaceuticals, intellectual property rights (IPR) and investment.
While the two sides made progress toward settling differences in these areas, no agreements resulted, said Deng, the chief representative of Taiwan's Office of Trade Negotiation and Taiwan's former No. 2 man in Washington.
Nevertheless, he said, he was satisfied with the session, the sixth between the two sides since the TIA was initiated in 1994.
"I am not disappointed," he said.
"I think the results are very positive. This is not the occasion to sign documents. All the agreements nowadays will involve a lot of experts. We cannot produce them in two days. But the important thing is using this opportunity to make sure we are working on the same goal, and we assured that. That we achieved, that is important," Deng said.
Overall US-Taiwan trade relations, the two sides agreed, "are healthy" he said, adding that it was agreed to expand the TIFA agreement to include more issues in the future. He did not give details.
On the piracy issue, much time was taken up by US concerns about illicit copying of material by students over the Education Ministry's TANet network at universities.
Lu Mu-lin (
"The US side was very satisfied with our efforts with respect to establishing a specialized IPR court, and passage of laws to handle internet infringement," Deng told the Taipei Times.
Despite this, the two sides apparently made no progress toward removing Taiwan from the USTR's so-called watch list of countries with serious piracy problems, under the USTR-administered so-called Special 301 trade law.
Varying degrees of progress were made on the three areas that were expected to be primary areas of attention: double taxation, Taiwanese government procurement, and investment access and protection.
On the investment issues, the two sides made "good progress," aided by four video conferences held before the Washington session to try to iron out problems, Deng said.
While the two sides continue to work toward an agreement, the negotiators set no timetable for reaching a final agreement, he said.
"We think we understand each other better now," he said.
On government procurement, the two sides agreed to "continue to work under the WTO framework," Deng said.
The double taxation issue was not discussed at any length, he said.
The one agreement the two sides did make was in the agricultural area, where they agreed to set up a "consultative agricultural mechanism" to allow the two sides to include more agricultural issues in their discussion with the aim of solving differences under that mechanism.
On pharmaceuticals, the two sides agreed to "work to fight counterfeit drugs" and to continue their dialogue on the pricing of medicines in Taiwan. Two working groups will carry out that work.
The meeting did not decide on a date for the next meeting, which, if tradition holds, will be in Taipei sometime next year.
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth